Hong Kong · Delayed Price · Currency is HKD Verve Therapeutics Statistics
Total Valuation
Sisram Medical has a market cap or net worth of HKD 2.70 billion. The enterprise value is 2.62 billion.
| Market Cap | 2.70B |
| Enterprise Value | 2.62B |
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | Aug 26, 2024 |
Share Statistics
Sisram Medical has 468.34 million shares outstanding.
| Current Share Class | 468.34M |
| Shares Outstanding | 468.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 0.56% |
| Float | 132.90M |
Valuation Ratios
The trailing PE ratio is 13.83 and the forward PE ratio is 8.47.
| PE Ratio | 13.83 |
| Forward PE | 8.47 |
| PS Ratio | 0.99 |
| PB Ratio | 0.72 |
| P/TBV Ratio | 1.78 |
| P/FCF Ratio | 11.45 |
| P/OCF Ratio | 10.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.49, with an EV/FCF ratio of 11.11.
| EV / Earnings | 13.42 |
| EV / Sales | 0.97 |
| EV / EBITDA | 7.49 |
| EV / EBIT | 12.17 |
| EV / FCF | 11.11 |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.61 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.96 |
| Debt / FCF | 1.42 |
| Interest Coverage | 11.27 |
Financial Efficiency
Return on equity (ROE) is 6.03% and return on invested capital (ROIC) is 3.32%.
| Return on Equity (ROE) | 6.03% |
| Return on Assets (ROA) | 2.79% |
| Return on Invested Capital (ROIC) | 3.32% |
| Return on Capital Employed (ROCE) | 5.20% |
| Revenue Per Employee | 2.69M |
| Profits Per Employee | 193,617 |
| Employee Count | 1,015 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, Sisram Medical has paid 29.32 million in taxes.
| Income Tax | 29.32M |
| Effective Tax Rate | 11.60% |
Stock Price Statistics
The stock price has increased by +81.70% in the last 52 weeks. The beta is 1.15, so Sisram Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +81.70% |
| 50-Day Moving Average | 4.77 |
| 200-Day Moving Average | 4.08 |
| Relative Strength Index (RSI) | 59.47 |
| Average Volume (20 Days) | 1,990,719 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sisram Medical had revenue of HKD 2.71 billion and earned 195.17 million in profits. Earnings per share was 0.42.
| Revenue | 2.71B |
| Gross Profit | 1.68B |
| Operating Income | 214.98M |
| Pretax Income | 252.76M |
| Net Income | 195.17M |
| EBITDA | 302.22M |
| EBIT | 214.98M |
| Earnings Per Share (EPS) | 0.42 |
Balance Sheet
The company has 576.00 million in cash and 335.56 million in debt, giving a net cash position of 240.44 million or 0.51 per share.
| Cash & Cash Equivalents | 576.00M |
| Total Debt | 335.56M |
| Net Cash | 240.44M |
| Net Cash Per Share | 0.51 |
| Equity (Book Value) | 3.77B |
| Book Value Per Share | 7.70 |
| Working Capital | 1.19B |
Cash Flow
In the last 12 months, operating cash flow was 256.97 million and capital expenditures -21.35 million, giving a free cash flow of 235.62 million.
| Operating Cash Flow | 256.97M |
| Capital Expenditures | -21.35M |
| Free Cash Flow | 235.62M |
| FCF Per Share | 0.50 |
Margins
Gross margin is 62.07%, with operating and profit margins of 7.93% and 7.20%.
| Gross Margin | 62.07% |
| Operating Margin | 7.93% |
| Pretax Margin | 9.32% |
| Profit Margin | 7.20% |
| EBITDA Margin | 11.14% |
| EBIT Margin | 7.93% |
| FCF Margin | 8.69% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 2.06%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 2.06% |
| Dividend Growth (YoY) | -8.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 37.61% |
| Buyback Yield | -0.21% |
| Shareholder Yield | 1.85% |
| Earnings Yield | 7.23% |
| FCF Yield | 8.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sisram Medical has an Altman Z-Score of 2.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.32 |
| Piotroski F-Score | 5 |